Clinical Trials Browser

Phase 2 × Small Cell Lung Carcinoma × selinexor × Clear all

NCT02351505 2016-05-16

Selinexor in Treating Patients With Relapsed Small Cell Lung Cancer

Phase 2 Terminated

1 enrolled 6 charts

Small Cell Lung Carcinoma